InvestorsHub Logo
Followers 241
Posts 12189
Boards Moderated 0
Alias Born 08/14/2003

Re: Palmer50 post# 685557

Tuesday, 04/16/2024 7:49:58 PM

Tuesday, April 16, 2024 7:49:58 PM

Post# of 694176
There are many ways to do this, one would be considered a franchise, another a contract, the key is, no matter how it's done, NWBO will be paid for every patient who receives the vaccine.

I believe the vehicle that makes all this possible is the EDEN unit, and I very much doubt if the units will ever be sold. Rather they'll be leased and NWBO will be responsible for their maintenance and updates as deemed necessary. I believe every disposable cassette will be tracked from manufacture thru vaccine generation, and finally to its being recycled.

I know most here don't agree that the EDEN should be leased to places like research institutions, universities, hospitals, etc. but I still believe under the right conditions it may be. If I were the company, and if UCLA were continuing to make their own DCVax-L for use in trials that they're running to build DCVax-L's effectiveness, I'd provide them with EDEN's to get that job done which also would eliminate any argument as to any difference between manually made vaccine and what's made in the EDEN. Of course the other possibility would be NWBO making every batch of vaccine for them using the EDEN.

Gary
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News